Published in Proteomics on April 13, 2016
Temporal profiles of plasma proteome during childhood development. J Proteomics (2016) 0.75
Proteomic profiling of human islets collected from frozen pancreata using laser capture microdissection. J Proteomics (2016) 0.75
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99
Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A (2001) 132.88
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res (2008) 54.83
PANTHER: a library of protein families and subfamilies indexed by function. Genome Res (2003) 21.64
Proteomics. Tissue-based map of the human proteome. Science (2015) 10.21
A draft map of the human proteome. Nature (2014) 6.58
PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways. Nucleic Acids Res (2006) 6.20
Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev (2011) 4.15
More than 100,000 detectable peptide species elute in single shotgun proteomics runs but the majority is inaccessible to data-dependent LC-MS/MS. J Proteome Res (2011) 3.53
Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer. J Proteome Res (2007) 3.48
Human postmortem tissue: what quality markers matter? Brain Res (2006) 2.92
Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes. Diabetes Metab Res Rev (2012) 1.68
Quantitative proteomic analysis of single pancreatic islets. Proc Natl Acad Sci U S A (2009) 1.62
Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics (2014) 1.59
Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med (2010) 1.59
Pancreas organ weight in individuals with disease-associated autoantibodies at risk for type 1 diabetes. JAMA (2012) 1.57
Detailed transcriptome atlas of the pancreatic beta cell. BMC Med Genomics (2009) 1.55
Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res (2007) 1.52
Systematic comparison of label-free, metabolic labeling, and isobaric chemical labeling for quantitative proteomics on LTQ Orbitrap Velos. J Proteome Res (2012) 1.50
A cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcription. Proc Natl Acad Sci U S A (1998) 1.37
Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes. Diabetes (2014) 1.34
Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K. J Biol Chem (1998) 1.32
Liquid chromatography-mass spectrometry-based quantitative proteomics. J Biol Chem (2011) 1.30
The pathogenesis and natural history of type 1 diabetes. Cold Spring Harb Perspect Med (2012) 1.30
Cul4A is an oncogene in malignant pleural mesothelioma. J Cell Mol Med (2011) 1.21
Reduction of circulating neutrophils precedes and accompanies type 1 diabetes. Diabetes (2013) 1.17
Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer. Neoplasia (2007) 1.17
Distinct roles of heterogeneous nuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100b, a ligand of the receptor for advanced glycation end products. J Biol Chem (2008) 1.14
Microscopic anatomy of the human islet of Langerhans. Adv Exp Med Biol (2010) 1.09
Inhibition of a NEDD8 Cascade Restores Restriction of HIV by APOBEC3G. PLoS Pathog (2012) 1.02
Simplified and versatile method for isolation of high-quality RNA from pancreas. Biotechniques (2012) 1.01
Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome. Proc Natl Acad Sci U S A (2012) 1.00
An AXL/LRP-1/RANBP9 complex mediates DC efferocytosis and antigen cross-presentation in vivo. J Clin Invest (2014) 0.99
Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes. J Exp Med (2012) 0.98
Exocrine pancreatic insufficiency in diabetes mellitus: a complication of diabetic neuropathy or a different type of diabetes? Exp Diabetes Res (2011) 0.98
Host heterogeneous ribonucleoprotein K (hnRNP K) as a potential target to suppress hepatitis B virus replication. PLoS Med (2005) 0.96
Circulating antibodies against an exocrine pancreatic enzyme in type 1 diabetes. Diabetes (1999) 0.96
Increased complement activation in human type 1 diabetes pancreata. Diabetes Care (2013) 0.96
Discovery of novel glucose-regulated proteins in isolated human pancreatic islets using LC-MS/MS-based proteomics. J Proteome Res (2012) 0.94
Two-dimensional protein database of human pancreas. Electrophoresis (2004) 0.93
CUL4A is overexpressed in human pituitary adenomas and regulates pituitary tumor cell proliferation. J Neurooncol (2014) 0.92
Comprehensive description of the N-glycoproteome of mouse pancreatic β-cells and human islets. J Proteome Res (2012) 0.92
Discovery and validation of serum protein changes in type 1 diabetes patients using high throughput two dimensional liquid chromatography-mass spectrometry and immunoassays. Mol Cell Proteomics (2011) 0.91
All human granzymes target hnRNP K that is essential for tumor cell viability. J Biol Chem (2012) 0.90
Over-expression of tetraspanin 8 in malignant glioma regulates tumor cell progression. Biochem Biophys Res Commun (2015) 0.89
Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays. Expert Rev Proteomics (2012) 0.88
Salivary proteins associated with hyperglycemia in diabetes: a proteomic analysis. Mol Biosyst (2013) 0.88
Detection of differential proteomes of human beta-cells during islet-like differentiation using iTRAQ labeling. J Proteome Res (2009) 0.86
Immunologic and metabolic biomarkers of β-cell destruction in the diagnosis of type 1 diabetes. Cold Spring Harb Perspect Med (2012) 0.85
A discovery-phase urine proteomics investigation in type 1 diabetes. Acta Diabetol (2012) 0.85
The pancreatic beta cell surface proteome. Diabetologia (2012) 0.85
Phosphotyrosine signaling analysis in human tumors is confounded by systemic ischemia-driven artifacts and intra-specimen heterogeneity. Cancer Res (2015) 0.84
Sparc-like protein 1 is a new marker of human glioma progression. J Proteome Res (2012) 0.84
Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins. J Virol (2014) 0.83
hnRNP-K is a nuclear target of TCR-activated ERK and required for T-cell late activation. Int Immunol (2009) 0.83
Comparison of label-free and label-based strategies for proteome analysis of hepatoma cell lines. Biochim Biophys Acta (2013) 0.83
Heterogeneous Nuclear Ribonucleoprotein M Facilitates Enterovirus Infection. J Virol (2015) 0.82
Losing a grip on the notion of β-cell specificity for immune responses in type 1 diabetes: can we handle the truth? Diabetes (2014) 0.82
Quantitative proteomics in cardiovascular research: global and targeted strategies. Proteomics Clin Appl (2014) 0.81
Recent findings and technological advances in phosphoproteomics for cells and tissues. Expert Rev Proteomics (2015) 0.81
Tetraspanin 8-rictor-integrin α3 complex is required for glioma cell migration. Int J Mol Sci (2015) 0.81
Identification of HNRNPK as regulator of hepatitis C virus particle production. PLoS Pathog (2015) 0.80
Protein profiling of pancreatic islets. Expert Rev Proteomics (2006) 0.80
An essential role of syntaxin 3 protein for granule exocytosis and secretion of IL-1α, IL-1β, IL-12b, and CCL4 from differentiated HL-60 cells. J Leukoc Biol (2014) 0.80
TBK1-associated protein in endolysosomes (TAPE)/CC2D1A is a key regulator linking RIG-I-like receptors to antiviral immunity. J Biol Chem (2012) 0.80
SIBLINGs and SPARC families: their emerging roles in pancreatic cancer. World J Gastroenterol (2014) 0.80
Heterogeneous nuclear ribonucleoprotein K supports vesicular stomatitis virus replication by regulating cell survival and cellular gene expression. J Virol (2013) 0.79
Proteomics in cancer research: Are we ready for clinical practice? Crit Rev Oncol Hematol (2015) 0.79
Syntaxin-4 is implicated in the secretion of antibodies by human plasma cells. J Leukoc Biol (2013) 0.78
Expression and subcellular localization of the Qa-SNARE syntaxin17 in human eosinophils. Exp Cell Res (2015) 0.78
The heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a host factor required for dengue virus and Junín virus multiplication. Virus Res (2015) 0.78
Using tissue samples for proteomic studies-critical considerations. Proteomics Clin Appl (2015) 0.77
Structure-Based Discovery of Novel Cyclophilin A Inhibitors for the Treatment of Hepatitis C Virus Infections. J Med Chem (2015) 0.77
TSPAN8, identified by Escherichia coli ampicillin secretion trap, is associated with cell growth and invasion in gastric cancer. Gastric Cancer (2015) 0.76
Application of proteomics in the study of rodent models of cancer. Proteomics Clin Appl (2014) 0.76
The beta-cell in type 1 diabetes: What have we learned from proteomic studies? Proteomics Clin Appl (2015) 0.76